-
-
Call more information
660-596-2224 -
AUTHORS: Engoren, Milo MD; Heung, Michael MD Anesthesia & Analgesia February 12, 2024. BACKGROUND: Sugammadex is associated with fewer postoperative pulmonary complications than is neostigmine reversal of neuromuscular blockade. However, the Food and Drug Administration-approved package insert states that its use is “not recommended” in severe renal impairment, separately defined as creatinine clearance <30 mL/min. […]
Read MoreAUTHORS: Yeh, Chou-Ming MD, PhD et al Anesthesia & Analgesia June 30, 2023. BACKGROUND: Paclitaxel (PTX), which is a first-line chemotherapy drug used to treat various types of cancers, exhibits peripheral neuropathy as a common side effect that is difficult to treat. Protein arginine methyltransferase 5 (PRMT 5) is a key regulator of the chemotherapy […]
Read MoreAUTHORS: Siddiqui, Shahla MD, MSc, FCCM et al Anesthesia & Analgesia 137(1):p 162-168, July 2023. BACKGROUND: Patient-centered care is increasing in importance especially in the post-coronavirus disease 2019 (COVID-19) pandemic era. We sought to understand factors affecting compassionate care faced by intensivists in the intensive care unit (ICU). METHODS: Using survey methodology incorporating 3 real-life case […]
Read MoreAuthors: Vijay Krishnamoorthy, M.D., M.P.H., Ph.D. et al Anesthesiology February 2024. Learning healthcare systems are a new and evolving way of integrating data and technology into daily practice in health care. Defined by the National Academy of Medicine (Washington, DC), a learning healthcare system is a system where “science, informatics, incentives, and culture are aligned for […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review Here are five anesthesiologists or anesthesia-related stories that have made headlines since Jan. 24: 1. Lubbock, Texas-based anesthesiologist Jeffrey Norman Colvin, MD, has been accused of violating a medical license restriction more than 60 times in two months and has been temporarily barred from practicing. The Texas Medical Board suspended Dr. […]
Read MoreAuthor: Carly Behm Becker’s Spine Review Spine surgery is a specialty that continues to grow in ASCs, and many physicians see a bright future for the outpatient setting as minimally invasive techniques and patient demand grow. Eight points on spine surgery and ASCs. 1. There are more than 180 ASCs in the U.S. that offer minimally invasive spine surgery. […]
Read MoreAuthor: L. JOSEPH PARKER, MD KevinMD.com A recent article in the Macomb Daily reported that a “Shelby Township doctor was convicted last Thursday of all counts for conspiring to distribute more than 300,000 opioid prescription pills valued at over $6 million, following a trial in U.S. District Court in Ann Arbor, according to federal authorities.” This sounds […]
Read MoreAuthors: Maarten van Lemmen, B.Sc. et al Anesthesiology February 2024. In Reply: We thank Dr. Pattullo and Drs. Milas and Varon for their interest and careful reading of our article on the use of naloxone in the reversal of an opioid overdose as might occur in the community setting in the United States. Individuals that […]
Read MoreAuthor: Gavin G. Pattullo, F.A.N.Z.C.A., F.F.P.M.A.N.Z.C.A. Anesthesiology February 2024. To the Editor: As clinicians, we often question why some patients respond to naloxone and others do not when opioid-induced ventilatory impairment is suspected. This inexplicability is disconcerting, given the toll of opioid-induced ventilatory impairment–related deaths. Our search for greater understanding, as recently provided in this […]
Read MoreAuthora: Bonnie L. Milas, M.D. et al Anesthesiology February 2024. To the Editor: As ASA members spearheading the REVIVEme.com initiative, we appreciate the thorough review of naloxone’s pharmacokinetics and dynamics by Lemmen et al. and the focus it brings to our Journal’s readers. It is clear that further study of opioid overdose reversal of respiratory depression […]
Read More